| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/03/1998 | US5723118 Therapeutic agents which are antagonists or partial agonists of human interleukin 4 |
| 03/03/1998 | US5723031 Method for the analytical separation of viruses |
| 03/03/1998 | CA1339694C Human high-affinity neurotranmitter uptake system |
| 02/26/1998 | WO1998008101A1 Materials and methods for detection and treatment of immune system dysfunctions |
| 02/26/1998 | WO1998008086A1 New kind of thin films for microsystem technology and microstructuring and their use |
| 02/26/1998 | WO1998008082A1 Transistor-based apparatus and method for molecular detection and field enhancement |
| 02/26/1998 | WO1998007887A1 METHODS FOR TREATING BIPOLAR MOOD DISORDER ASSOCIATED WITH MARKERS ON CHROMOSOMES 18p |
| 02/26/1998 | WO1998007886A1 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 02/26/1998 | WO1998007881A1 T1 receptor-like ligand i |
| 02/26/1998 | WO1998007880A1 Human endokine alpha |
| 02/26/1998 | WO1998007878A2 Long-term expression of gene products by transforming muscle cells |
| 02/26/1998 | WO1998007877A1 A short-shafted adenoviral fiber and its use |
| 02/26/1998 | WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | WO1998007875A1 Method for inducing viral resistance into a plant |
| 02/26/1998 | WO1998007874A2 New systems for regulating genetic expression |
| 02/26/1998 | WO1998007873A1 Yeast vectors and process for producing proteins with the use of the same |
| 02/26/1998 | WO1998007872A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis |
| 02/26/1998 | WO1998007871A1 Modified forms of trimethylamine dehydrogenase (tmadh) with increased substrate specificity |
| 02/26/1998 | WO1998007869A1 HBV POLYMERASE, RNase H ENZYME DERIVED FROM HBV POLYMERASE, PROCESSES FOR PREPARATION AND USES FOR SCREENING ANTIVIRAL AGENTS THEREOF |
| 02/26/1998 | WO1998007868A1 Rifamycin biosynthesis gene cluster |
| 02/26/1998 | WO1998007866A1 Antigenic protein originating in infectious laryngotracheitis virus |
| 02/26/1998 | WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs |
| 02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
| 02/26/1998 | WO1998007863A1 HUMAN INTERFERON τ VARIANTS |
| 02/26/1998 | WO1998007862A2 Chemokine beta-16 |
| 02/26/1998 | WO1998007861A1 Anti-proliferative factor from transfected cells |
| 02/26/1998 | WO1998007860A1 HUMAN POLYHOMEOTIC 1 (hph1) ACTS AS AN ONCOGENE |
| 02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007858A1 HUMAN POLYHOMEOTIC 1(hphl) ACTS AS A TUMOR SUPPRESSOR |
| 02/26/1998 | WO1998007857A1 Reagents and methods useful for detecting diseases of the breast |
| 02/26/1998 | WO1998007856A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007854A1 Human glycine transporter |
| 02/26/1998 | WO1998007853A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007852A1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination |
| 02/26/1998 | WO1998007851A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 02/26/1998 | WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 02/26/1998 | WO1998007849A1 Madr2 tumour suppressor gene |
| 02/26/1998 | WO1998007847A1 M. tuberculosis complex members mycobacteria specific nucleic acid fragments and their applications for the detection and differential diagnosis of m. tuberculosis complex members |
| 02/26/1998 | WO1998007846A1 Artificial promoter libraries for selected organisms and promoters derived from such libraries |
| 02/26/1998 | WO1998007845A1 Interaction trap assay, reagents and uses thereof |
| 02/26/1998 | WO1998007842A1 Methods for improving seeds |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | WO1998007840A1 Novel dnas and process for producing proteins by using the same |
| 02/26/1998 | WO1998007838A1 Higher animal telomerase protein and gene encoding the same |
| 02/26/1998 | WO1998007837A1 Improved nucleic acids for reducing carbohydrate epitopes |
| 02/26/1998 | WO1998007836A1 Manipulation of proanthocyanidin biosynthesis |
| 02/26/1998 | WO1998007835A2 Crystal structures of a protein tyrosine kinase |
| 02/26/1998 | WO1998007834A2 Materials and methods for increasing corn seed weight |
| 02/26/1998 | WO1998007833A1 Compositions and methods for use of defensin |
| 02/26/1998 | WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | WO1998007829A8 Use of flexible plastic tanks in gene theraphy |
| 02/26/1998 | WO1998007829A2 Use of flexible plastic tanks in gene theraphy |
| 02/26/1998 | WO1998007754A1 T1 receptor-like ligand ii |
| 02/26/1998 | WO1998007747A1 Transformed wheat having improved breadmaking characteristics |
| 02/26/1998 | WO1998007745A2 Compositions and methods for treating infections using analogues of indolicidin |
| 02/26/1998 | WO1998007738A1 Immunoglobulin trans-spliced transcripts and uses thereof |
| 02/26/1998 | WO1998007737A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | WO1998007734A1 Oligonucleotide prodrugs |
| 02/26/1998 | WO1998007733A1 Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof |
| 02/26/1998 | WO1998007444A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 02/26/1998 | WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 02/26/1998 | WO1998007426A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
| 02/26/1998 | WO1998007415A2 Methods for prevention of cellular proliferation and restenosis |
| 02/26/1998 | WO1998007408A1 Novel liposome complexes for increased systemic delivery |
| 02/26/1998 | WO1998007320A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM) |
| 02/26/1998 | WO1998007310A1 Insect-resistant transgenic eggplant and method of making |
| 02/26/1998 | WO1998003669A3 Vectors for inhibiting hiv and tumor growth |
| 02/26/1998 | WO1998003652A3 P300/cbp-associated transcriptional co-factor p/caf and uses thereof |
| 02/26/1998 | WO1998003200A3 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 02/26/1998 | WO1998002546A3 Dna immunization against chlamydia infection |
| 02/26/1998 | WO1998002536A3 Preparation of pichia methanolica auxotrophic mutants |
| 02/26/1998 | WO1998002534A3 Transgenic animal whose expression of the opiate receptors is modified |
| 02/26/1998 | WO1998001570A3 Mutated antibody-dependent infection enhancing domains of hiv |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997049807A3 A novel hypertension related calcium regulated gene (hcarg) |
| 02/26/1998 | WO1997046681A3 Galanin receptor galr2 |
| 02/26/1998 | WO1997043409A3 Method of providing novel dna sequences |
| 02/26/1998 | WO1997039123A3 Secreted proteins |
| 02/26/1998 | WO1997029199A3 Prostate specific antigen peptides and uses thereof |
| 02/26/1998 | DE19732135A1 Gefrorenes Nahrungsmittelprodukt A frozen food product |
| 02/26/1998 | DE19707493C1 Nucleic acid construct for trans-gene expression |
| 02/26/1998 | DE19649207C1 Nucleic acid characteristic of late or early passage cells immortalised by papilloma virus |
| 02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
| 02/26/1998 | DE19633698A1 Neue Systeme zur Regulation der Genexpression New systems for the regulation of gene expression |
| 02/26/1998 | CA2269654A1 Long-term expression of gene products by transforming muscle cells |
| 02/26/1998 | CA2264952A1 Improved nucleic acids for reducing carbohydrate epitopes |
| 02/26/1998 | CA2264271A1 Transformed wheat having improved breadmaking characteristics |
| 02/26/1998 | CA2264205A1 Use of flexible plastic tanks in gene therapy |
| 02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
| 02/26/1998 | CA2264201A1 Manipulation of proanthocyanidin biosynthesis |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2264198A1 Methods for treating bipolar mood disorder associated with markers on chromosomes 18p |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264054A1 Method for determining expression of aberrant forms of apc protein |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
| 02/26/1998 | CA2263875A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction |